A new study published in The Lancet Oncology discusses the efficacy of anastrozole, a molecule used to prevent breast cancer in postmenopausal women with a high risk of breast cancer. Breast ...

Mauras et al. conducted a double-blind, randomized, placebo-controlled trial to determine whether estrogen suppression with the selective aromatase inhibitor anastrozole, administered to growth ...

Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...

Anastrozole, used for many years to treat the disease, has now been licensed as a preventative option. Recent trials show the drug can reduce the incidence of breast cancer by almost 50% in post ...